ACTRN12619000418178尚未招募4 期
Palmitoylethanolamide for the treatment of chronic nociplastic pain: a randomised double-blind placebo-controlled trial.
Daniel Ellyard0 个研究点目标入组 100 人开始时间: 2019年3月14日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Chronic pain at least 3 months duration AND
- •Evidence of centralised pain/ neuroinflammatory response as evidenced by Symptom Severity Score (from Fibromyalgia Survey Score) greater than or equal to 7/12 AND
- •Average pain intensity as measured by modified BPI greater than or equal to 5/10 (moderate or severe) AND
- •Pain interference as measure by BPI greater than or equal to 5/10 (moderate or severe)
排除标准
- •Daily opioids > 120 OME
- •Planned procedural intervention within 6 months
- •Pre-study use of PEA
- •Workers compensation or other ongoing compensation claim
- •Major psychiatric disease (BPAD, Psychosis, PTSD)
- •Pregnancy or breastfeeding
- •Non-English speaking
- •Cognitive impairment significant enough to impair informed consent
研究者
相似试验
招募中
不适用
Palmitoylethanolamide as adjunctive treatment of Autism: A double blind and placebo controlled trialChildhood autism.Childhood autismIRCT201702171556N96Tehran University of Medical Sciences50
尚未招募
2 期
The effect of Palmitoylethanolamide on the treatment of negative symptoms in patients with chronic schizophreniaSchizophreniaIRCT20090117001556N127Tehran University of Medical Sciences50
招募中
不适用
Palmitoylethanolamide in the treatment of major depressioMajor Depressive Disorder.Major Depressive DisorderIRCT201702181556N97Tehran University of Medical Sciences50
已完成
不适用
Palmitoylethanolamide intake and systemic endothelial function in ocular hypertensive patientsEye DiseasesOcular hypertensionISRCTN72647928niversity of Bologna (Italy)80
进行中（未招募）
1 期
The use of Thalidomide as a treatment for the cachexia of incurable upper gastrointestinal adenocarcinomas:a randomised, double-blinded, placebo controlled trial. - Thalidomide in cancer cachexiaEUCTR2005-000371-18-GBPortsmouth Hospitals Trust180